| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 68.80B | 66.08B | 64.86B | 60.27B | 60.04B | 59.19B |
| Gross Profit | 15.31B | 14.40B | 12.52B | 11.97B | 11.08B | 11.20B |
| EBITDA | 6.15B | 5.73B | 4.36B | 3.27B | 2.58B | 2.55B |
| Net Income | 4.29B | 4.01B | 2.66B | 1.92B | 1.53B | 1.57B |
Balance Sheet | ||||||
| Total Assets | 55.26B | 64.14B | 60.43B | 58.74B | 50.93B | 53.31B |
| Cash, Cash Equivalents and Short-Term Investments | 16.60B | 15.45B | 13.06B | 12.07B | 11.45B | 10.78B |
| Total Debt | 725.00M | 740.00M | 900.00M | 1.27B | 1.28B | 1.02B |
| Total Liabilities | 24.60B | 33.31B | 32.93B | 34.34B | 27.89B | 31.34B |
| Stockholders Equity | 30.46B | 30.61B | 27.28B | 24.20B | 22.84B | 21.75B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.17B | 631.00M | 2.85B | 887.00M | -650.00M |
| Operating Cash Flow | 0.00 | 3.48B | 809.00M | 2.92B | 1.72B | 532.00M |
| Investing Cash Flow | 0.00 | 10.00M | 848.00M | -1.49B | -759.00M | 342.00M |
| Financing Cash Flow | 0.00 | -763.00M | -848.00M | -663.00M | -298.00M | -12.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥44.93B | 5.27 | ― | 3.87% | 1.84% | -2.64% | |
77 Outperform | ¥314.75B | 20.97 | ― | 1.68% | 8.46% | 26.64% | |
72 Outperform | ¥33.46B | 9.39 | ― | 4.05% | 5.23% | 0.62% | |
71 Outperform | ¥62.58B | 13.36 | ― | 1.22% | 16.37% | 76.33% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥68.98B | 15.26 | ― | 3.17% | 4.04% | 7.40% | |
61 Neutral | ¥142.63B | 9.09 | ― | 2.42% | 8.46% | -3.62% |